HMEZX
Price
$19.92
Change
-$0.02 (-0.10%)
Updated
Dec 18 closing price
VARBX
Price
$10.52
Change
-$0.00 (-0.00%)
Updated
Dec 18 closing price
Ad is loading...

HMEZX vs VARBX

Header iconHMEZX vs VARBX Comparison
Open Charts HMEZX vs VARBXBanner chart's image
NexPoint Merger Arbitrage Z
Price$19.92
Change-$0.02 (-0.10%)
VolumeN/A
CapitalizationN/A
First Trust Merger Arbitrage Cl I
Price$10.52
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
HMEZX vs VARBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HMEZX vs. VARBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMEZX is a Buy and VARBX is a Hold.

FUNDAMENTALS
Fundamentals
VARBX has more cash in the bank: 1.46B vs. HMEZX (798M). HMEZX pays higher dividends than VARBX: HMEZX (5.06) vs VARBX (3.37). HMEZX was incepted earlier than VARBX: HMEZX (8 years) vs VARBX (9 years). HMEZX is a more actively managed with annual turnover of: 646.00 vs. VARBX (367.00). HMEZX has a lower initial minimum investment than VARBX: HMEZX (2500) vs VARBX (100000). HMEZX annual gain was more profitable for investors over the last year : 5.74 vs. VARBX (1.69). HMEZX return over 5 years is better than : 19.56 vs. VARBX (9.42).
HMEZXVARBXHMEZX / VARBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD5.7361.503382%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets798M1.46B55%
Annual Yield % from dividends5.063.37150%
Returns for 1 year5.741.69339%
Returns for 3 years10.976.31174%
Returns for 5 years19.569.42208%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALA6.190.08
+1.31%
Kala BIO
LNTH92.66-0.82
-0.88%
Lantheus Holdings
HEI259.80-3.00
-1.14%
HEICO Corp
NRDS13.31-0.16
-1.19%
NerdWallet
LXRX0.73-0.04
-4.64%
Lexicon Pharmaceuticals